HomeCompareOMGA vs KMB

OMGA vs KMB: Dividend Comparison 2026

OMGA yields 1402.52% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OMGA wins by $381345977.97M in total portfolio value
10 years
OMGA
OMGA
● Live price
1402.52%
Share price
$0.14
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$381345978.01M
Annual income
$334,438,358,870,850.44
Full OMGA calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.35
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,222.34
Full KMB calculator →

Portfolio growth — OMGA vs KMB

📍 OMGA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOMGAKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OMGA + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OMGA pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OMGA
Annual income on $10K today (after 15% tax)
$119,214.59/yr
After 10yr DRIP, annual income (after tax)
$284,272,605,040,222.90/yr
KMB
Annual income on $10K today (after 15% tax)
$446.39/yr
After 10yr DRIP, annual income (after tax)
$4,438.99/yr
At 15% tax rate, OMGA beats the other by $284,272,605,035,783.90/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OMGA + KMB for your $10,000?

OMGA: 50%KMB: 50%
100% KMB50/50100% OMGA
Portfolio after 10yr
$190672989.03M
Annual income
$167,219,179,438,036.38/yr
Blended yield
87.70%
📊

Analyst Conviction Gap

Where Wall Street is split right now

OMGA
Analyst Ratings
6
Buy
1
Hold
Consensus: Buy
Price Target
$9.00
+6211.4% upside vs current
Range: $7.00 — $11.00
Altman Z
-5.0
Piotroski
4/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.7% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OMGA buys
0
KMB buys
0
No recent congressional trades found for OMGA or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOMGAKMB
Forward yield1402.52%5.25%
Annual dividend / share$2.00$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17%
Portfolio after 10y$381345978.01M$45.9K
Annual income after 10y$334,438,358,870,850.44$5,222.34
Total dividends collected$377907407.35M$21.6K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold
Analyst price target$9.00$123.00

Year-by-year: OMGA vs KMB ($10,000, DRIP)

YearOMGA PortfolioOMGA Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$150,952$140,252.45$11,314$614.45+$139.6KOMGA
2$2,140,160$1,978,640.40$12,867$760.19+$2.13MOMGA
3$28,507,337$26,217,366.21$14,713$945.27+$28.49MOMGA
4$356,877,024$326,374,173.75$16,924$1,181.90+$356.86MOMGA
5$4,200,368,557$3,818,510,141.40$19,596$1,486.64+$4200.35MOMGA
6$46,497,265,746$42,002,871,390.15$22,850$1,882.16+$46497.24MOMGA
7$484,297,536,606$434,545,462,256.76$26,849$2,399.80+$484297.51MOMGA
8$4,748,158,615,450$4,229,960,251,282.26$31,812$3,083.36+$4748158.58MOMGA
9$43,838,896,396,104$38,758,366,677,572.48$38,033$3,994.72+$43838896.36MOMGA
10$381,345,978,014,682$334,438,358,870,850.44$45,918$5,222.34+$381345977.97MOMGA

OMGA vs KMB: Complete Analysis 2026

OMGAStock

Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-regulate the expression of HNF4a, a transcriptional master regulator as a potential way to restore liver-cell function in patients suffering from chronic liver diseases; to control the expression of genes that have been strongly linked to cell-growth inhibition in patients with diabetes and other conditions to restore the capacity for corneal regeneration; to down-regulate expression of the CXCL1, 2, 3, and IL-8 gene cluster; to control expression of genes implicated in patients with idiopathic pulmonary fibrosis to halt or reverse disease progression and improve disease outcomes; to down-regulate the expression of SFRP1, a protein that inhibits hair growth; and to treat non-small cell lung cancer and small cell lung cancer. It is also developing OTX-2002 to down-regulate c-Myc, an oncogene. The company was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Full OMGA Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this OMGA vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OMGA vs SCHDOMGA vs JEPIOMGA vs OOMGA vs KOOMGA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.